Abstract
Use of the ST. JUDE MEDICAL® cardiac valve was begun as a limited trial in high-risk subsets of valve recipients in March 1978. As of March 1984, we have implanted 442 valves in 382 patients. There has been increasing clinical utilization of this prosthesis in many other centers since the valve’s FDA approval. However, the responsibility of the original clinical investigators is to continually review and analyze the experience with the earliest recipients of this prosthesis to address the as yet unanswered question about its long-term durability. Accordingly, we recently analyzed the clinical results of our patients with a maximum of 5 years follow-up and a minimum of one year follow-up.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Gray, R.J., Chaux, A., Czer, L.S.C., Derobertis, M., Matloff, J.M. (1985). A 60-Month Experience with the ST. JUDE MEDICAL® Prosthesis at Cedars-Sinai Medical Center. In: Matloff, J.M. (eds) Cardiac Valve Replacement. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2601-4_23
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2601-4_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9629-4
Online ISBN: 978-1-4613-2601-4
eBook Packages: Springer Book Archive